Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
276
DELISTED
Abiomed Inc
ABMD
| $74.7M | 0.1% |
256,733
-197,706
| -44% | -$50.1M |
|
277
Allstate
ALL
$64.2B
| $74.6M | 0.1% |
787,419
+316,423
| +67% | +$30.7M |
|
278
Coherent
COHR
$56.7B
| $74.4M | 0.1% |
1,818,415
+803,698
| +79% | +$34.8M |
|
279
MGM Resorts International
MGM
$11B
| $74.4M | 0.1% |
2,123,384
-335,161
| -14% | -$11.8M |
|
280
Unum
UNM
$13.9B
| $73.8M | 0.1% |
1,550,354
+738,146
| +91% | +$38.6M |
|
281
Camden Property Trust
CPT
$10.8B
| $73.7M | 0.1% |
875,619
+509,066
| +139% | +$42.5M |
|
282
Edwards Lifesciences
EW
$51.8B
| $73.6M | 0.1% |
1,581,723
-874,113
| -36% | -$38M |
|
|
WP
283
DELISTED
Worldpay, Inc.
WP
| $73.4M | 0.1% |
+892,902
| New | +$70.8M |
|
284
Berkshire Hathaway Class B
BRK.B
$1.06T
| $73.3M | 0.1% |
367,340
+195,213
| +113% | +$40.1M |
|
285
Ameriprise Financial
AMP
$49.1B
| $73.1M | 0.1% |
494,341
+333,623
| +208% | +$54.4M |
|
286
Netflix
NFLX
$331B
| $72.5M | 0.1% |
2,454,410
+1,611,430
| +191% | +$43.9M |
|
287
Comcast
CMCSA
$95.3B
| $72.2M | 0.1% |
2,111,884
-1,422,836
| -40% | -$55.2M |
|
|
WLL
288
DELISTED
Whiting Petroleum Corporation
WLL
| $72.1M | 0.1% |
28,412
+8,799
| +45% | +$18.9M |
|
289
Applied Materials
AMAT
$391B
| $71.9M | 0.1% |
1,292,595
-1,094,937
| -46% | -$61M |
|
|
PPLI
290
People Inc
PPLI
$2.86B
| $71.8M | 0.1% |
2,569,769
+826,369
| +47% | +$21.8M |
|
291
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $71.6M | 0.1% |
609,841
+100,652
| +20% | +$11.9M |
|
|
SPLK
292
DELISTED
Splunk Inc
SPLK
| $71.4M | 0.1% |
725,772
+364,320
| +101% | +$34.8M |
|
293
Icon
ICLR
$13.3B
| $71.2M | 0.1% |
602,923
-3,347
| -0.6% | -$384K |
|
|
PCH
294
DELISTED
PotlatchDeltic
PCH
| $70.7M | 0.09% |
1,357,937
+456,375
| +51% | +$23.7M |
|
295
Digital Realty Trust
DLR
$70.5B
| $70.6M | 0.09% |
670,027
+633,960
| +1,758% | +$66.9M |
|
296
Hartford Financial Services
HIG
$36.9B
| $70.5M | 0.09% |
1,367,682
-591,210
| -30% | -$32.3M |
|
297
Regeneron Pharmaceuticals
REGN
$85.9B
| $69.7M | 0.09% |
202,346
-275,898
| -58% | -$96M |
|
298
PUT
GE Aerospace
GE
$361B
| $69.4M | 0.09% |
1,074,610
+396,458
| +58% | +$29.4M |
|
299
DexCom
DXCM
$34.8B
| $68.9M | 0.09% |
3,717,916
+2,093,752
| +129% | +$31M |
|
300
Bio-Rad Laboratories Class A
BIO
$10.2B
| $68.8M | 0.09% |
275,220
+95,218
| +53% | +$24.2M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.